LifestyleAdvancement that could revolutionize automated dosing systems for everyone

Advancement that could revolutionize automated dosing systems for everyone

Innovative Approach to Universal Drug Monitoring and Dosing

Researchers at Rice University have developed a groundbreaking method to utilize existing glucose monitoring technology for the monitoring and dosing of a wide range of medications. The study, recently published in Nature Communications, showcased how a blood-glucose sensor was modified to detect the anticancer drug afimoxifene, demonstrating the versatility of this approach.

Expanding the Potential of Biosensing Technology

The team led by Caroline Ajo-Franklin capitalized on the well-established biosensing technology available in the market for glucose monitoring, which is both affordable and accessible. By repurposing this technology, the researchers aim to accelerate the development of automated dosing systems for various drugs, including chemotherapies, and enable real-time monitoring of blood biomarkers.

Towards Personalized Drug Dosing

Ajo-Franklin envisions a future where drug monitoring and dosing can be as straightforward and efficient as monitoring blood glucose levels. By leveraging the advancements in biosensing technology, the team aims to revolutionize the current one-size-fits-all approach to drug dosing, offering tailored solutions for individual patients.

Innovative Protein Modifications for Drug Detection

In their study, Rong Cai and the research team experimented with modifying proteins to detect afimoxifene, showcasing how subtle alterations to existing technology can yield significant results. By identifying a protein variant that reacts specifically to the presence of the drug, the researchers were able to detect afimoxifene accurately.

Integration of Technology for Real-World Application

Collaborating with experts in engineering and materials science, Ajo-Franklin’s team successfully created an electronic device capable of detecting afimoxifene. This integration of biosensing technology into practical devices paves the way for future applications in drug monitoring and dosing.

Future Directions and Advancements

Looking ahead, Ajo-Franklin’s lab is actively exploring ways to enhance the sensitivity of glucose-based drug tests and identify proteins that can detect a wider range of drugs. The adaptability of this technology means that with minor adjustments, existing devices can be repurposed for different drug monitoring purposes.

Evolving Towards Digital Health Solutions

One key advantage of this technology is its ability to generate electrical output, enabling seamless integration with digital platforms for data storage and analysis. By leveraging this feature, users can easily track and monitor their medication intake, leading to more personalized and efficient healthcare solutions.

Overall, by repurposing existing biosensing technology, researchers at Rice University have opened up a new realm of possibilities for universal drug monitoring and dosing. This innovative approach holds promise for revolutionizing the way medications are administered, moving towards a more personalized and efficient healthcare system.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Subscribe Today

GET EXCLUSIVE FULL ACCESS TO PREMIUM CONTENT

SUPPORT NONPROFIT JOURNALISM

EXPERT ANALYSIS OF AND EMERGING TRENDS IN CHILD WELFARE AND JUVENILE JUSTICE

TOPICAL VIDEO WEBINARS

Get unlimited access to our EXCLUSIVE Content and our archive of subscriber stories.

Exclusive content

Latest article

More article